Rosatom R&D Business Unit has its own research and technological base for producing isotopes that is in demand on both Russian and international markets. It is expanding its expertise in producing ready-to-use radiopharmaceuticals and medical devices for treating serious diseases, including cancer.
Rosatom R&D Business Unit includes JSC Isotope, the industry integrator for the supply and promotion of isotope products, as well as research institutes that produce isotopes: Karpov Institute of Physical Chemistry, Research Institute of Atomic Reactors (RIAR), Institute of Nuclear Materials (INM), Leypunsky Institute for Physics and Power Engineering (IPPE), and Khlopin Radium Institute.
Rosatom’s radionuclide portfolio includes more than 300 isotopes, and the range of isotope products used in medicine, science, and industry comprises over 400 items.